{"id":2123,"date":"2021-12-14T00:00:00","date_gmt":"2021-12-14T05:00:00","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/"},"modified":"2023-06-14T19:43:15","modified_gmt":"2023-06-14T23:43:15","slug":"trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/","title":{"rendered":"Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020"},"content":{"rendered":"<p><strong>Aim <\/strong>&#x2014; To examine trends in basal insulin prescribing in older adults with CKD.<\/p>\n<p><span class=\"bold\">Materials and Methods <\/span>&#x2014; We conducted a population-based study of adults &#x2265;66 years with treated diabetes between January 1 2010 to September 1 2020 in Ontario, Canada. We examined prevalent and incident prescriptions for human neutral protamine Hagedorn, Levemir, glargine-100, Basaglar, glargine-300 and degludec insulin over 43 study intervals. We present trends in those with CKD, and in a subgroup, by estimated glomerular filtration rate (eGFR). To provide context for prescribing, we provide demographics, comorbidities, and the healthcare utilization of included patients.<\/p>\n<p><strong>Results <\/strong>&#x2014; In CKD, use of basal insulin was about 2-fold higher than in the general treated diabetes cohort. Prescriptions for NPH declined over time, while prescriptions for Levemir and glargine-100 increased until 2018 and then fell. Following drug formulary approval (September 2018), prescriptions for glargine-300 and degludec increased substantially.<\/p>\n<p>Incident prescriptions for basal insulin in CKD declined over time; however in those an eGFR &lt;30ml\/min\/1.73m<sup>2<\/sup> rates remained stable. In recent years, rates of degludec and glargine-300 have rivalled glargine-100.<\/p>\n<p><strong>Conclusions <\/strong>&#x2014; In an era of new oral and injectable diabetes medications, use of basal insulin has declined in older adults with CKD. However, in those with more advanced CKD, basal insulin, particularly newer analogues, remain a mainstay treatment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aim &#x2014; To examine trends in basal insulin prescribing in older adults with CKD. Materials and Methods &#x2014; We conducted a population-based study of adults &#x2265;66 years with treated diabetes between January 1 2010 to September 1 2020 in Ontario, Canada. We examined prevalent and incident prescriptions for human neutral protamine Hagedorn, Levemir, glargine-100, Basaglar, [&hellip;]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[],"migration-helper-qa-sample-set":[],"class_list":["post-2123","journal_article","type-journal_article","status-publish","hentry"],"acf":{"citation":"Clemens KK, Ou&#xe9;draogo AM, Lam M, Muanda Tsobo F, Loeschnik E, Wilk P, Shariff SZ. <em>Diabetes Obes Metab<\/em>. 2022; 24(4):641-51. Epub 2021 Dec 14.","source_url":"https:\/\/doi.org\/10.1111\/dom.14622","ices_scientist":[1206,1359,1130,13130],"site":[6739],"research_program":[6743],"news_release":[],"journal_article":[],"atlas":[],"research_report":[],"infographic":[],"video":[],"downloads":null,"links":null,"sitecore_item_id":"276F577E-2B41-4464-8D02-73045B6BDE72","sitecore_item_name":"Trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-Ontario-Canada","sitecore_field_values":"{\n  \"Title\": \"Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020\",\n  \"Short title\": \"Trends in basal insulin prescribing in\",\n  \"Summary\": \"This study aimed to examine trends in basal insulin prescribing in older adults with chronic kidney disease.\",\n  \"Citation\": \"<p>Clemens KK, Ou&eacute;draogo AM, Lam M, Muanda Tsobo F, Loeschnik E, Wilk P, Shariff SZ. <em>Diabetes Obes Metab<\/em>. 2022; 24(4):641-51. Epub 2021 Dec 14. DOI: <a href=\"https:\/\/doi.org\/10.1111\/dom.14622\" title=\"Opens external link\">https:\/\/doi.org\/10.1111\/dom.14622<\/a><\/p>\",\n  \"Abstract\": \"<p><strong>Aim <\/strong>&mdash; To examine trends in basal insulin prescribing in older adults with CKD.<\/p>n<p><span class=\"bold\">Materials and Methods <\/span>&mdash; We conducted a population-based study of adults &ge;66 years with treated diabetes between January 1 2010 to September 1 2020 in Ontario, Canada. We examined prevalent and incident prescriptions for human neutral protamine Hagedorn, Levemir, glargine-100, Basaglar, glargine-300 and degludec insulin over 43 study intervals. We present trends in those with CKD, and in a subgroup, by estimated glomerular filtration rate (eGFR). To provide context for prescribing, we provide demographics, comorbidities, and the healthcare utilization of included patients.<\/p>n<p><strong>Results <\/strong>&mdash; In CKD, use of basal insulin was about 2-fold higher than in the general treated diabetes cohort. Prescriptions for NPH declined over time, while prescriptions for Levemir and glargine-100 increased until 2018 and then fell. Following drug formulary approval (September 2018), prescriptions for glargine-300 and degludec increased substantially.<\/p>n<p>Incident prescriptions for basal insulin in CKD declined over time; however in those an eGFR &lt;30ml\/min\/1.73m<sup>2<\/sup> rates remained stable. In recent years, rates of degludec and glargine-300 have rivalled glargine-100.<\/p>n<p><strong>Conclusions <\/strong>&mdash; In an era of new oral and injectable diabetes medications, use of basal insulin has declined in older adults with CKD. However, in those with more advanced CKD, basal insulin, particularly newer analogues, remain a mainstay treatment.<\/p>\",\n  \"Research Programs\": \"{92CC48EB-79AA-49F6-8A80-16D185170261}\",\n  \"ICES Locations\": \"{3B4AF7E8-6835-410B-AEB8-360A79CA0ED8}\",\n  \"ICES Scientists\": \"{7EFBF915-676D-48BE-85DF-2F7508D9BAF9}|{E8DA0CD3-1341-4EA5-846D-D3FCFCEB3137}|{FA3E4AF1-35B0-44AC-8848-7582FC8C2F95}|{EB6115E7-E1A9-4DEC-B7C5-1C094C16CCDE}\",\n  \"Posted Date\": \"20211214T000000\",\n  \"Show on Publications Landing Page\": \"1\"\n}","previous_url":"https:\/\/www.ices.on.ca\/Publications\/Journal-Articles\/2021\/December\/Trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-Ontario-Canada"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICES | Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020<\/title>\n<meta name=\"description\" content=\"Aim &#x2014; To examine trends in basal insulin prescribing in older adults with CKD. Materials and Methods &#x2014; We conducted a population-based study\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020\" \/>\n<meta property=\"og:description\" content=\"Aim &#x2014; To examine trends in basal insulin prescribing in older adults with CKD. Materials and Methods &#x2014; We conducted a population-based study\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-14T23:43:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\\\/\",\"name\":\"ICES | Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2021-12-14T05:00:00+00:00\",\"dateModified\":\"2023-06-14T23:43:15+00:00\",\"description\":\"Aim &#x2014; To examine trends in basal insulin prescribing in older adults with CKD. Materials and Methods &#x2014; We conducted a population-based study\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020","description":"Aim &#x2014; To examine trends in basal insulin prescribing in older adults with CKD. Materials and Methods &#x2014; We conducted a population-based study","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020","og_description":"Aim &#x2014; To examine trends in basal insulin prescribing in older adults with CKD. Materials and Methods &#x2014; We conducted a population-based study","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2023-06-14T23:43:15+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/","name":"ICES | Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2021-12-14T05:00:00+00:00","dateModified":"2023-06-14T23:43:15+00:00","description":"Aim &#x2014; To examine trends in basal insulin prescribing in older adults with CKD. Materials and Methods &#x2014; We conducted a population-based study","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/trends-in-basal-insulin-prescribing-in-older-adults-with-chronic-kidney-disease-in-ontario-canada-a-population-based-analysis-between-from-2010-to-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: a population-based analysis between from 2010 to 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/2123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/research_program\/6743"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6739"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/13130"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1130"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1359"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1206"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=2123"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=2123"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=2123"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=2123"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=2123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}